BIOFILM-RESPONSIVE PRODRUG DESIGN: AN EMERGING MEDICINAL CHEMISTRY STRATEGY AGAINST ANTIMICROBIAL RESISTANCE
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Antimicrobial resistance remains one of the most serious threats to global health, and biofilm-associated infections represent one of its most therapeutically resistant manifestations. Conventional antibiotics are commonly optimized against planktonic bacteria, yet their clinical performance often decreases in mature biofilms because of poor penetration, altered microenvironmental conditions, metabolic heterogeneity, and the presence of tolerant subpopulations. In response to these limitations, medicinal chemistry is increasingly shifting from the design of broadly active antibacterial agents toward the development of context-dependent systems capable of selective activation at the site of infection. One of the most promising directions in this regard is biofilm-responsive prodrug design. This article reviews the medicinal chemistry rationale behind prodrugs that remain relatively stable during systemic transport but undergo activation in biofilm-specific microenvironments. Particular attention is paid to pH-responsive, enzyme-responsive, redox-responsive, and metabolite-guided activation mechanisms, as well as to the role of linker engineering, physicochemical optimization, and release kinetics in achieving effective antibacterial action. The paper also examines the potential of multifunctional designs that combine antibiotic release with antibiofilm, quorum-sensing-interfering, or antivirulence effects. In addition, key translational barriers are analyzed, including biofilm heterogeneity, insufficient predictive screening models, safety concerns, and regulatory complexity. It is argued that biofilm-responsive prodrugs may redefine anti-infective medicinal chemistry by integrating drug transport, site-selective activation, and microenvironment-aware therapeutic action into a single molecular strategy
Fields of Study & Subjects
Bacterial biofilms and quorum sensing
Antimicrobial agents and applications
Advanced Drug Delivery Systems
Publication details
- Journal / source
- Sciences of Europe
- Publication date
- 30 March 2026
- Language
- EN